Table 6 Differences in vascular changes in non-T2D subjects without or without treatment with any type of RAAS inhibitor

ABPI

146

76

1.16 (1.08–1.25)

1.13 (1.02–1.23)

ns

49

196

1.17 (1.12–1.23)

1.17 (1.10–1.25)

ns

CCA IMT (mm)

147

73

0.88 (0.78–1.04)

0.88 (0.78–0.99)

ns

48

192

0.92 (0.82–1.03)

0.81 (0.72–0.96)

7.4E-04

Bulb IMT (mm)

132

66

1.20 (0.98–1.44)

1.07 (0.96–1.31)

ns

47

187

1.15 (0.99–1.38)

0.96 (0.84–1.15)

1.9E-04

Plaque area (mm²)

128

67

18.5 (12.5–24.6)

13.58 (10.9–18.7)

0.004

40

134

15.8 (10.7–29.8)

13.2 (7.8–20.0)

ns

PWV (m/sec)

135

63

10.2 (8.3–11.8)

9.7 (8.5–11.8)

ns

46

189

9.8 (9.0–11.0)

9.2 (7.9–10.7)

0.025

RHI

158

77

2.2 (1.8–2.6)

2.3 (1.9–2.7)

ns

50

196

2.25 (1.88–2.48)

2.41 (2.00–2.81)

ns